The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Antifungal drug-resistance mechanisms in Candida biofilms
Open accessAbstract
Infections caused by the Candida species of human fungal pathogens are a significant medical problem because they can disseminate to nearly every organ of the body. In addition, there are only a few classes of antifungal drugs available to treat patients with invasive fungal infections. Candida infections that are associated with biofilms can withstand much higher concentrations of antifungal drugs compared with infections caused by planktonic cells, thus making biofilm infections particularly challenging to treat. Candida albicans is among the most prevalent fungal species of the human microbiota, asymptomatically colonizing several niches of the body, including the gastrointestinal tract, genitourinary tract, mouth, and skin. Immunocompromised health conditions, dysbiosis of the microbiota, or environmental changes, however, can lead to C. albicans overgrowth, causing infections that range from superficial mucosal infections to severe hematogenously disseminated infections. Here, we review the current knowledge of antifungal drug-resistance mechanisms occurring in Candida biofilms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
Tackling the emerging threat of antifungal resistance to human health
Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00720-1 · Cited by 1,179
Candida albicans Biofilms and Human Disease
Nobile, C. J., & Johnson, A. D. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104330 · Cited by 1,057
Self-citationQuorum Sensing in the Dimorphic Fungus Candida albicans Is Mediated by Farnesol
Hornby, J. M., Jensen, E. C., Lisec, A. D., Tasto, J. J., Jahnke, B., Shoemaker, R., Dussault, P., & Nickerson, K. W. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.7.2982-2992.2001 · Cited by 983
Fungal Community Analysis by Large-Scale Sequencing of Environmental Samples
O'Brien, H. E., Parrent, J. L., Jackson, J. A., Moncalvo, J.-M., & Vilgalys, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.9.5544-5550.2005 · Cited by 953
Multidrug Tolerance of Biofilms and Persister Cells
Lewis, K. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75418-3_6 · Cited by 804
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Candida albicans biofilms: development, regulation, and molecular mechanisms
Gulati, M., & Nobile, C. J. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.01.002 · Cited by 738
Self-citationA Recently Evolved Transcriptional Network Controls Biofilm Development in Candida albicans
Nobile, C. J., Fox, E. P., Nett, J. E., Sorrells, T. R., Mitrovich, Q. M., Hernday, A. D., Tuch, B. B., Andes, D. R., & Johnson, A. D. (2012) · Cell · doi:10.1016/j.cell.2011.10.048 · Cited by 711
Self-citationInhibition of Candida albicans Biofilm Formation by Farnesol, a Quorum-Sensing Molecule
Ramage, G., Saville, S. P., Wickes, B. L., & López-Ribot, J. L. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.11.5459-5463.2002 · Cited by 701
Development and regulation of single- and multi-species Candida albicans biofilms
Lohse, M. B., Gulati, M., Johnson, A. D., & Nobile, C. J. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.107 · Cited by 643
Self-citationHarriott, M. M., & Noverr, M. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00657-09 · Cited by 529
Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells
LaFleur, M. D., Kumamoto, C. A., & Lewis, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00684-06 · Cited by 521
Tyrosol is a quorum-sensing molecule in Candida albicans
Chen, H., Fujita, M., Feng, Q., Clardy, J., & Fink, G. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401416101 · Cited by 498
Pathogenesis and virulence of Candida albicans
Lopes, J. P., & Lionakis, M. S. (2022) · Virulence · doi:10.1080/21505594.2021.2019950 · Cited by 477
Ramage, G. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf049 · Cited by 468
Molecular Evolution of Antifungal Drug Resistance
Robbins, N., Caplan, T., & Cowen, L. E. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-030117-020345 · Cited by 441
The Spectrum of Fungi That Infects Humans
Kohler, J. R., Casadevall, A., & Perfect, J. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019273 · Cited by 364
de Oliveira Santos, G. C., Vasconcelos, C. C., Lopes, A. J. O., de Sousa Cartágenes, M. D. S., Filho, A. K. D. B., do Nascimento, F. R. F., Ramos, R. M., Pires, E. R. R. B., de Andrade, M. S., Rocha, F. M. G., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01351 · Cited by 350
LaFayette, S. L., Collins, C., Zaas, A. K., Schell, W. A., Betancourt-Quiroz, M., Gunatilaka, A. A. L., Perfect, J. R., & Cowen, L. E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001069 · Cited by 329 · cited 1×
“Indeed, pharmacological inhibition of calcineurin or Hsp90 is synergistic with fluconazole against C. albicans biofilms [21,47].”
Novel Entries in a Fungal Biofilm Matrix Encyclopedia
Zarnowski, R., Westler, W. M., Lacmbouh, G. A., Marita, J. M., Bothe, J. R., Bernhardt, J., Lounes-Hadj Sahraoui, A., Fontaine, J., Sanchez, H., Hatfield, R. D., et al. (2014) · mBio · doi:10.1128/mbio.01333-14 · Cited by 315
Kong, E. F., Tsui, C., Kucharíková, S., Andes, D., Van Dijck, P., & Jabra-Rizk, M. A. (2016) · mBio · doi:10.1128/mbio.01365-16 · Cited by 294
Hsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms
Robbins, N., Uppuluri, P., Nett, J., Rajendran, R., Ramage, G., Lopez-Ribot, J. L., Andes, D., & Cowen, L. E. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002257 · Cited by 291
A Candida Biofilm-Induced Pathway for Matrix Glucan Delivery: Implications for Drug Resistance
Taff, H. T., Nett, J. E., Zarnowski, R., Ross, K. M., Sanchez, H., Cain, M. T., Hamaker, J., Mitchell, A. P., & Andes, D. R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002848 · Cited by 291
Recent insights into Candida albicans biofilm resistance mechanisms
Mathé, L., & Van Dijck, P. (2013) · Current Genetics · doi:10.1007/s00294-013-0400-3 · Cited by 271
Alem, M. A. S., Oteef, M. D. Y., Flowers, T. H., & Douglas, L. J. (2006) · Eukaryotic Cell · doi:10.1128/ec.00219-06 · Cited by 254
Patients with Long-Term Oral Carriage Harbor High-Persister Mutants of Candida albicans
LaFleur, M. D., Qi, Q., & Lewis, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00860-09 · Cited by 237
Evolution of the human pathogenic lifestyle in fungi
Rokas, A. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01112-0 · Cited by 232
Synergistic Effect of Calcineurin Inhibitors and Fluconazole against Candida albicans Biofilms
Uppuluri, P., Nett, J., Heitman, J., & Andes, D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01397-07 · Cited by 228
Balashov, S. V., Park, S., & Perlin, D. S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01653-05 · Cited by 225
Cao, Y.-Y., Cao, Y.-B., Xu, Z., Ying, K., Li, Y., Xie, Y., Zhu, Z.-Y., Chen, W.-S., & Jiang, Y.-Y. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.584-589.2005 · Cited by 222
A contact-activated kinase signals Candida albicans invasive growth and biofilm development
Kumamoto, C. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407097102 · Cited by 209
Kumamoto, C. A., Gresnigt, M. S., & Hube, B. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.05.006 · Cited by 208
Nett, J. E., Crawford, K., Marchillo, K., & Andes, D. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00227-10 · Cited by 207 · cited 2×
“…antifungal drug resistance, and it has been shown that increased expression of FKS1 impacts the susceptibility of C. albicans biofilms to antifungal drugs by increasing the levels of biofilm matrix sequestration, thus preventing the antifungal drugs from reaching their cellular targets [33].”
Community participation in biofilm matrix assembly and function
Mitchell, K. F., Zarnowski, R., Sanchez, H., Edward, J. A., Reinicke, E. L., Nett, J. E., Mitchell, A. P., & Andes, D. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421437112 · Cited by 183
Contributions of the Biofilm Matrix to Candida Pathogenesis
Nett, J. E., & Andes, D. R. (2020) · Journal of Fungi · doi:10.3390/jof6010021 · Cited by 179
Diagnosis and Treatment of Invasive Candidiasis
Barantsevich, N., & Barantsevich, E. (2022) · Antibiotics · doi:10.3390/antibiotics11060718 · Cited by 178
Fungi of the human gut microbiota: Roles and significance
Pérez, J. C. (2021) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2021.151490 · Cited by 173
Role for Cell Density in Antifungal Drug Resistance in Candida albicans Biofilms
Perumal, P., Mekala, S., & Chaffin, W. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01237-06 · Cited by 165
Johnson, C. J., Cabezas‐Olcoz, J., Kernien, J. F., Wang, S. X., Beebe, D. J., Huttenlocher, A., Ansari, H., & Nett, J. E. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005884 · Cited by 148
Kim, D., Liu, Y., Benhamou, R. I., Sánchez, H., Simón‐Soro, Á., Li, Y. H., Hwang, G., Fridman, M., Andes, D. R., & Koo, H. (2018) · The ISME Journal · doi:10.1038/s41396-018-0113-1 · Cited by 145
Conserved Role for Biofilm Matrix Polysaccharides in Candida auris Drug Resistance
Dominguez, E. G., Zarnowski, R., Choy, H. L., Zhao, M., Sanchez, H., Nett, J. E., & Andes, D. R. (2019) · mSphere · doi:10.1128/mspheredirect.00680-18 · Cited by 132 · cited 1×
“The importance of matrix glucans and mannans in contributing to biofilm drug tolerance appears to be a conserved mechanism that is also known to occur in biofilms formed by other Candida species, such as Candida glabrata, Candida parapsilosis, Candida tropicalis, and Candida auris [8,9].”
Romo, J. A., & Kumamoto, C. A. (2020) · Journal of Fungi · doi:10.3390/jof6010016 · Cited by 124
Coordination of fungal biofilm development by extracellular vesicle cargo
Zarnowski, R., Noll, A., Chevrette, M. G., Sanchez, H., Jones, R., Anhalt, H., Fossen, J., Jaromin, A., Currie, C., Nett, J. E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26525-z · Cited by 123 · cited 2×
“For example, the tos1Δ/Δ strain showed enhanced antifungal susceptibility in C. albicans, C. tropicalis, C. parapsilosis, C. glabrata, and C. auris relative to its complemented strain [50,51].”
Rodrigues, C. F., & Černáková, L. (2020) · Genes · doi:10.3390/genes11040444 · Cited by 111
Brucker, K. D., Tan, Y., Vints, K., Cremer, K. D., Braem, A., Verstraeten, N., Michiels, J. J., Vleugels, J., Cammue, B. P. A., & Thevissen, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04650-14 · Cited by 107
Vila, T. V. M., Kong, E. F., Montelongo‐Jauregui, D., Dijck, P. V., Shetty, A. C., McCracken, C. L., Bruno, V. M., & Jabra‐Rizk, M. A. (2021) · Virulence · doi:10.1080/21505594.2021.1894834 · Cited by 98
Dominguez, E., Zarnowski, R., Sanchez, H., Covelli, A. S., Westler, W. M., Azadi, P., Nett, J., Mitchell, A. P., & Andes, D. R. (2018) · mBio · doi:10.1128/mbio.00451-18 · Cited by 77
A common vesicle proteome drives fungal biofilm development
Zarnowski, R., Sanchez, H., Jaromin, A., Zarnowska, U. J., Nett, J. E., Mitchell, A. P., & Andes, D. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211424119 · Cited by 63
Monteiro, D. R., Arias, L. S., Fernandes, R. A., da Silva, L. F. D., de Castilho, M. O. V. F., Rosa, T., Vieira, A. P. M., Straioto, F. G., Barbosa, D. B., & Delbem, A. C. B. (2017) · Journal of Applied Microbiology · doi:10.1111/jam.13513 · Cited by 49
Interactions of microorganisms with host mucins: a focus on Candida albicans
Arevalo, A. V., & Nobile, C. J. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa027 · Cited by 40
Self-citationPhysiological and Transcriptional Responses of Candida parapsilosis to Exogenous Tyrosol
Jakab, Á., Tóth, Z., Nagy, F., Nemes, D., Bácskay, I., Kardos, G., Emri, T., Pócsi, I., Majoros, L., & Kovács, R. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.01388-19 · Cited by 34
Cited by
Antifungal therapy of Candida biofilms: Past, present and future
Ajetunmobi, O. H., Badali, H., Romo, J. A., Ramage, G., & Lopez-Ribot, J. L. (2023) · Biofilm · doi:10.1016/j.bioflm.2023.100126 · Cited by 52
Pan, Y., Sun, Y., Chen, L., Cheng, Y., Jin, P., Zhang, W., Zheng, L., Liu, J., Zhou, T., Xu, Z., et al. (2023) · Biofilm · doi:10.1016/j.bioflm.2023.100162 · Cited by 26
Metadata
- Authors
- Kaur, J., & Nobile, C. J.
- Venue
- Current Opinion in Microbiology
- Publisher
- Elsevier BV
- Published
- 2023-02
- Volume
- 71
- Pages
- 102237
- ISSN
- 1369-5274 (ISSN-L)
- OpenAlex
- W4310355275
- Cited by
- 261
- References
- 52
- FWCI
- 8.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.